439 related articles for article (PubMed ID: 27939301)
41. Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system.
Moricoli D; Muller WA; Carbonella DC; Balducci MC; Dominici S; Watson R; Fiori V; Weber E; Cianfriglia M; Scotlandi K; Magnani M
J Immunol Methods; 2014 Jun; 408():35-45. PubMed ID: 24798881
[TBL] [Abstract][Full Text] [Related]
42. Expression, purification and characterization of refolded rBm-33 (pepsin inhibitor homolog) from Brugia malayi: a human Lymphatic Filarial parasite.
Krishna NR; Krushna NS; Narayanan RB; Rajan SS; Gunasekaran K
Protein Expr Purif; 2011 Oct; 79(2):245-50. PubMed ID: 21745575
[TBL] [Abstract][Full Text] [Related]
43. Development of Solubilization and Refolding Buffers.
Roufarshbaf M; Akbari V
Methods Mol Biol; 2023; 2617():155-164. PubMed ID: 36656522
[TBL] [Abstract][Full Text] [Related]
44. Purification and refolding of anti-T-antigen single chain antibodies (scFvs) expressed in Escherichia coli as inclusion bodies.
Yuasa N; Koyama T; Fujita-Yamaguchi Y
Biosci Trends; 2014 Feb; 8(1):24-31. PubMed ID: 24647109
[TBL] [Abstract][Full Text] [Related]
45. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.
Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z
Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092
[TBL] [Abstract][Full Text] [Related]
46. Endotoxin-free purification for the isolation of bovine viral diarrhoea virus E2 protein from insoluble inclusion body aggregates.
Cavallaro AS; Mahony D; Commins M; Mahony TJ; Mitter N
Microb Cell Fact; 2011 Jul; 10():57. PubMed ID: 21787435
[TBL] [Abstract][Full Text] [Related]
47. A comparative approach to recombinantly produce the plant enzyme horseradish peroxidase in Escherichia coli.
Gundinger T; Spadiut O
J Biotechnol; 2017 Apr; 248():15-24. PubMed ID: 28288816
[TBL] [Abstract][Full Text] [Related]
48. Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli.
Bu D; Zhou Y; Tang J; Jing F; Zhang W
Protein Expr Purif; 2013 Dec; 92(2):203-7. PubMed ID: 24128692
[TBL] [Abstract][Full Text] [Related]
49. Refolding single-chain antibody (scFv) using lauroyl-L-glutamate as a solubilization detergent and arginine as a refolding additive.
Kudou M; Ejima D; Sato H; Yumioka R; Arakawa T; Tsumoto K
Protein Expr Purif; 2011 May; 77(1):68-74. PubMed ID: 21195184
[TBL] [Abstract][Full Text] [Related]
50. Production of Stabilized Antibody Fragments in the E. coli Bacterial Cytoplasm and in Transiently Transfected Mammalian Cells.
Birnboim-Perach R; Grinberg Y; Vaks L; Nahary L; Benhar I
Methods Mol Biol; 2019; 1904():455-480. PubMed ID: 30539486
[TBL] [Abstract][Full Text] [Related]
51. Expression of fibronectin-binding protein of L. acidophilus NCFM and in vitro refolding to adhesion capable native-like protein from inclusion bodies.
Bisht S; Singh KS; Choudhary R; Kumar S; Grover S; Mohanty AK; Pande V; Kaushik JK
Protein Expr Purif; 2018 May; 145():7-13. PubMed ID: 29229289
[TBL] [Abstract][Full Text] [Related]
52. Effects of ionic strength on inclusion body refolding at high concentration.
Gabrielczyk J; Kluitmann J; Dammeyer T; Jördening HJ
Protein Expr Purif; 2017 Feb; 130():100-106. PubMed ID: 27751932
[TBL] [Abstract][Full Text] [Related]
53. Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies.
Williamson RA; Natalia D; Gee CK; Murphy G; Carr MD; Freedman RB
Eur J Biochem; 1996 Oct; 241(2):476-83. PubMed ID: 8917445
[TBL] [Abstract][Full Text] [Related]
54. Solubilization of recombinant ovine growth hormone with retention of native-like secondary structure and its refolding from the inclusion bodies of Escherichia coli.
Khan RH; Rao KB; Eshwari AN; Totey SM; Panda AK
Biotechnol Prog; 1998; 14(5):722-8. PubMed ID: 9758661
[TBL] [Abstract][Full Text] [Related]
55. Heterologous expression, purification and single step efficient refolding of recombinant tissue plasminogen activator (Reteplase) from E. coli.
Bhatt M; Masi HA; Patel A; Singh NK; Joshi C
Protein Expr Purif; 2024 Sep; 221():106504. PubMed ID: 38782082
[TBL] [Abstract][Full Text] [Related]
56. High pressure refolding, purification, and crystallization of flavin reductase from Sulfolobus tokodaii strain 7.
Okai M; Ohtsuka J; Asano A; Guo L; Miyakawa T; Miyazono K; Nakamura A; Okada A; Zheng H; Kimura K; Nagata K; Tanokura M
Protein Expr Purif; 2012 Aug; 84(2):214-8. PubMed ID: 22722101
[TBL] [Abstract][Full Text] [Related]
57. Unit Operation-Spanning Investigation of the Redox System.
Ebner J; Humer D; Sedlmayr V
Methods Mol Biol; 2023; 2617():165-176. PubMed ID: 36656523
[TBL] [Abstract][Full Text] [Related]
58. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
[TBL] [Abstract][Full Text] [Related]
59. Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies.
McConnell MJ; Pachón J
Protein Expr Purif; 2011 May; 77(1):98-103. PubMed ID: 21130880
[TBL] [Abstract][Full Text] [Related]
60. Refolding and purification of yeast carboxypeptidase Y expressed as inclusion bodies in Escherichia coli.
Hahm MS; Chung BH
Protein Expr Purif; 2001 Jun; 22(1):101-7. PubMed ID: 11388806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
